COLL
Price
$30.23
Change
+$0.89 (+3.03%)
Updated
May 16 closing price
Capitalization
1.24B
75 days until earnings call
INDV
Price
$11.34
Change
+$0.27 (+2.44%)
Updated
May 16 closing price
Capitalization
2.91B
68 days until earnings call
Ad is loading...

COLL vs INDV

Header iconCOLL vs INDV Comparison
Open Charts COLL vs INDVBanner chart's image
Collegium Pharmaceutical
Price$30.23
Change+$0.89 (+3.03%)
Volume$430.85K
Capitalization1.24B
Indivior
Price$11.34
Change+$0.27 (+2.44%)
Volume$1.09M
Capitalization2.91B
COLL vs INDV Comparison Chart
Loading...
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COLL vs. INDV commentary
May 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COLL is a Hold and INDV is a Hold.

Ad is loading...
COMPARISON
Comparison
May 17, 2025
Stock price -- (COLL: $29.34 vs. INDV: $11.07)
Brand notoriety: COLL and INDV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: COLL: 90% vs. INDV: 62%
Market capitalization -- COLL: $1.24B vs. INDV: $2.91B
COLL [@Pharmaceuticals: Other] is valued at $1.24B. INDV’s [@Pharmaceuticals: Other] market capitalization is $2.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COLL’s FA Score shows that 2 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • COLL’s FA Score: 2 green, 3 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, COLL is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COLL’s TA Score shows that 6 TA indicator(s) are bullish while INDV’s TA Score has 5 bullish TA indicator(s).

  • COLL’s TA Score: 6 bullish, 4 bearish.
  • INDV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, COLL is a better buy in the short-term than INDV.

Price Growth

COLL (@Pharmaceuticals: Other) experienced а +7.59% price change this week, while INDV (@Pharmaceuticals: Other) price change was +0.82% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.72%. For the same industry, the average monthly price growth was +12.60%, and the average quarterly price growth was +27.89%.

Reported Earning Dates

COLL is expected to report earnings on Jul 31, 2025.

INDV is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.72% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.91B) has a higher market cap than COLL($1.24B). INDV has higher P/E ratio than COLL: INDV (2102.00) vs COLL (30.17). COLL YTD gains are higher at: 2.408 vs. INDV (-10.941). COLL has higher annual earnings (EBITDA): 308M vs. INDV (66M). INDV has more cash in the bank: 410M vs. COLL (311M). INDV has less debt than COLL: INDV (282M) vs COLL (674M). INDV has higher revenues than COLL: INDV (1.09B) vs COLL (567M).
COLLINDVCOLL / INDV
Capitalization1.24B2.91B43%
EBITDA308M66M467%
Gain YTD2.408-10.941-22%
P/E Ratio30.172102.001%
Revenue567M1.09B52%
Total Cash311M410M76%
Total Debt674M282M239%
FUNDAMENTALS RATINGS
COLL vs INDV: Fundamental Ratings
COLL
INDV
OUTLOOK RATING
1..100
2070
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
5764
SMR RATING
1..100
3077
PRICE GROWTH RATING
1..100
5647
P/E GROWTH RATING
1..100
1198
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COLL's Valuation (62) in the Pharmaceuticals Other industry is somewhat better than the same rating for INDV (100) in the null industry. This means that COLL’s stock grew somewhat faster than INDV’s over the last 12 months.

COLL's Profit vs Risk Rating (57) in the Pharmaceuticals Other industry is in the same range as INDV (64) in the null industry. This means that COLL’s stock grew similarly to INDV’s over the last 12 months.

COLL's SMR Rating (30) in the Pharmaceuticals Other industry is somewhat better than the same rating for INDV (77) in the null industry. This means that COLL’s stock grew somewhat faster than INDV’s over the last 12 months.

INDV's Price Growth Rating (47) in the null industry is in the same range as COLL (56) in the Pharmaceuticals Other industry. This means that INDV’s stock grew similarly to COLL’s over the last 12 months.

COLL's P/E Growth Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for INDV (98) in the null industry. This means that COLL’s stock grew significantly faster than INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COLLINDV
RSI
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
74%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
66%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 6 days ago
70%
Declines
ODDS (%)
Bearish Trend 26 days ago
65%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

COLL and

Correlation & Price change

A.I.dvisor tells us that COLL and AMPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COLL and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+0.93%
AMPH - COLL
31%
Poorly correlated
+4.38%
ALKS - COLL
30%
Poorly correlated
+1.93%
SUPN - COLL
27%
Poorly correlated
+2.98%
ZTS - COLL
27%
Poorly correlated
+3.51%
RDY - COLL
27%
Poorly correlated
+1.77%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and EBS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+0.36%
EBS - INDV
28%
Poorly correlated
-2.66%
COLL - INDV
21%
Poorly correlated
+0.93%
ALKS - INDV
21%
Poorly correlated
+1.93%
OPTN - INDV
21%
Poorly correlated
+1.06%
ESPR - INDV
21%
Poorly correlated
+6.47%
More